These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37227658)

  • 1. Exploring Barriers and Facilitators to Integrating a Harm Reduction Approach to Substance Use in Three Medical Settings.
    Lindenfeld Z; Hagan H; Chang JE
    J Gen Intern Med; 2023 Nov; 38(15):3273-3282. PubMed ID: 37227658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating Harm Reduction into Medical Care: Lessons from Three Models.
    Chang JE; Lindenfeld Z; Hagan H
    J Am Board Fam Med; 2023 May; 36(3):449-461. PubMed ID: 37169587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facilitators and barriers to the implementation of new critical care practices during COVID-19: a multicenter qualitative study using the Consolidated Framework for Implementation Research (CFIR).
    Silver S; Jones KC; Redmond S; George E; Zornes S; Barwise A; Leppin A; Dong Y; Harmon LA; Kumar VK; Kordik C; Walkey AJ; Drainoni ML
    BMC Health Serv Res; 2023 Mar; 23(1):272. PubMed ID: 36941593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The integration of harm reduction services in the Veterans Health Administration (VHA): a qualitative analysis of barriers and facilitators.
    Harvey LH; Sliwinski SK; Flike K; Boudreau J; Gifford AL; Branch-Elliman W; Hyde J
    J Addict Dis; 2023 May; ():1-9. PubMed ID: 37154222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barriers and facilitators affecting the implementation of substance use screening in primary care clinics: a qualitative study of patients, providers, and staff.
    McNeely J; Kumar PC; Rieckmann T; Sedlander E; Farkas S; Chollak C; Kannry JL; Vega A; Waite EA; Peccoralo LA; Rosenthal RN; McCarty D; Rotrosen J
    Addict Sci Clin Pract; 2018 Apr; 13(1):8. PubMed ID: 29628018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. American Indian and Alaska Native substance use treatment: Barriers and facilitators according to an implementation framework.
    Shukla R; Turner BJ; Ramos GG; Love M; D'Isabella J; Soto C
    J Subst Use Addict Treat; 2023 Dec; 155():209095. PubMed ID: 37277023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of an integrated infectious disease and substance use disorder team for injection drug use-associated infections: a qualitative study.
    Hervera B; Seo G; Bartholomew TS; Chueng TA; Suarez E; Forrest DW; Hernandez S; Rodriguez AE; Tookes HE; Doblecki-Lewis S; Serota DP
    Addict Sci Clin Pract; 2023 Feb; 18(1):8. PubMed ID: 36747268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barriers and facilitators to HPV vaccination in primary care practices: a mixed methods study using the Consolidated Framework for Implementation Research.
    Garbutt JM; Dodd S; Walling E; Lee AA; Kulka K; Lobb R
    BMC Fam Pract; 2018 May; 19(1):53. PubMed ID: 29734944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring Chiropractic Services in the Canadian Forces Health Services - Perceptions of Facilitators and Barriers Among Key Informants.
    Mior SA; Vogel E; Sutton D; French S; Côté P; Nordin M; Loisel P; Laporte A
    Mil Med; 2019 May; 184(5-6):e344-e351. PubMed ID: 30462275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers and Facilitators to Establishing Partnerships for Substance Use Disorder Care Transitions Between Safety-Net Hospitals and Community-Based Organizations.
    Lindenfeld Z; Franz B; Lai AY; Pagán JA; Fenstemaker C; Cronin CE; Chang JE
    J Gen Intern Med; 2024 Sep; 39(12):2150-2159. PubMed ID: 38937366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integration of a community-based harm reduction program into a safety net hospital: a qualitative study.
    Khan GK; Harvey L; Johnson S; Long P; Kimmel S; Pierre C; Drainoni ML
    Harm Reduct J; 2022 Apr; 19(1):35. PubMed ID: 35414072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of buprenorphine services in NYC syringe services programs: a qualitative process evaluation.
    Jakubowski A; Rath C; Harocopos A; Wright M; Welch A; Kattan J; Navos Behrends C; Lopez-Castro T; Fox AD
    Harm Reduct J; 2022 Jul; 19(1):75. PubMed ID: 35818071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barriers and facilitators to implementing cancer prevention clinical decision support in primary care: a qualitative study.
    Harry ML; Truitt AR; Saman DM; Henzler-Buckingham HA; Allen CI; Walton KM; Ekstrom HL; O'Connor PJ; Sperl-Hillen JM; Bianco JA; Elliott TE
    BMC Health Serv Res; 2019 Jul; 19(1):534. PubMed ID: 31366355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient perspectives on a harm reduction-oriented addiction medicine consultation team implemented in a large acute care hospital.
    Hyshka E; Morris H; Anderson-Baron J; Nixon L; Dong K; Salvalaggio G
    Drug Alcohol Depend; 2019 Nov; 204():107523. PubMed ID: 31541875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "It's a proactive intervention instead of a reactive one": measuring facilitators and barriers regarding readiness to implement a treatment program for infants with neonatal opioid withdrawal syndrome.
    Holcomb L; Koob C; Mayo R; Charron E; Dickes L; Sherrill W; Hudson J
    BMC Health Serv Res; 2023 Jul; 23(1):754. PubMed ID: 37452415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for Substance Use in Rural Primary Care: a Qualitative Study of Providers and Patients.
    Saunders EC; Moore SK; Gardner T; Farkas S; Marsch LA; McLeman B; Meier A; Nesin N; Rotrosen J; Walsh O; McNeely J
    J Gen Intern Med; 2019 Dec; 34(12):2824-2832. PubMed ID: 31414355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying Common and Unique Barriers and Facilitators to Implementing Evidence-Based Practices for Suicide Prevention across Primary Care and Specialty Mental Health Settings.
    Davis M; Siegel J; Becker-Haimes EM; Jager-Hyman S; Beidas RS; Young JF; Wislocki K; Futterer A; Mautone JA; Buttenheim AM; Mandell DS; Marx D; Wolk CB
    Arch Suicide Res; 2023; 27(2):192-214. PubMed ID: 34651544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barriers and facilitators of implementing the practice programme for upright positions in the second stage of labour: A mixed-method study.
    Huang J; Wang B; Sun K; Zhang H; Bai F; Lian H; Lei C; Cheng Y; Nie K; Zang Y
    J Adv Nurs; 2023 Nov; ():. PubMed ID: 37921103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "It's Like A Partnership": Exploring the Primary Care Experiences and Patient-Defined Goals of People Who Use Drugs.
    Dunham K; Rivas C; Medina Blanco P; Kolod B; Salvati C; Clark K; Sue KL; Hagaman A; Weiss JJ
    J Gen Intern Med; 2024 Jul; 39(9):1681-1689. PubMed ID: 38578536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementing alcohol use disorder pharmacotherapy in primary care settings: a qualitative analysis of provider-identified barriers and impact on implementation outcomes.
    Hagedorn HJ; Wisdom JP; Gerould H; Pinsker E; Brown R; Dawes M; Dieperink E; Myrick DH; Oliva EM; Wagner TH; Harris AHS
    Addict Sci Clin Pract; 2019 Jul; 14(1):24. PubMed ID: 31291996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.